Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.57219 | 87 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.348 | 85 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.23555 | 84 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.65066 | 86 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.4736 | 85 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.89181 | 83 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.17239 | 85 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.17441 | 84 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.31386 | 85 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.34374 | 85 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.40601 | 85 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.49854 | 85 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.42206 | 85 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.15141 | 84 |